論文

査読有り 国際誌
2020年12月

New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression

Current Opinion in Immunology
  • Norihisa Mikami
  • ,
  • Ryoji Kawakami
  • ,
  • Shimon Sakaguchi

67
開始ページ
36
終了ページ
41
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.coi.2020.07.004
出版者・発行元
Elsevier BV

Naturally occurring FoxP3+CD4+ regulatory T (Treg) cells indispensable for the maintenance of immunological self-tolerance and homeostasis are instrumental in treating autoimmune and other immunological disorders. Stable function of natural Treg cells requires not only the expression of Foxp3 and other Treg signature genes such as CD25 and CTLA-4 but also the generation of Treg-specific epigenetic changes, especially Treg-specific DNA hypomethylation, at these gene loci. Recent studies have shown that the Treg-specific transcriptional and epigenetic changes can be induced in antigen-specific conventional T cells in vivo and in vitro, converting them to functionally stable Treg cells. Such natural or induced Treg cells bear the potential to achieve stable antigen-specific immune suppression and reestablish immunological self-tolerance in treating and preventing autoimmune diseases.

リンク情報
DOI
https://doi.org/10.1016/j.coi.2020.07.004
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32827951
ID情報
  • DOI : 10.1016/j.coi.2020.07.004
  • ISSN : 0952-7915
  • PubMed ID : 32827951

エクスポート
BibTeX RIS